DNA methylation in the APOE gene: its link with Alzheimer’s and cardiovascular health
Mur, J.; McCartney, D. L.; Walker, R. M.; Campbell, A.; Bermingham, M. L.; Morris, S. W.; Porteous, D. J.; McIntosh, A. M.; Deary, I. J.; Evans, K. L.; Marioni, R. E.
Show abstract
Genetic variation in the apolipoprotein E (APOE) gene is associated with Alzheimers disease (AD) and risk factors for cardiovascular disease (CVD). DNA methylation at APOE has been linked to altered cognition and AD. It is unclear if epigenetic marks could be used for predicting future disease. We assessed blood-based DNA methylation at 13 CpGs in the APOE gene in 5828 participants from the Generation Scotland (GS) cohort. Using linear regression, we examined the relationship between APOE methylation, cognition, cholesterol, and the risks for AD and CVD. DNA methylation at two CpGs was associated with the ratio of total-to-HDL cholesterol, but not with cognition, or the risks of AD or CVD. APOE methylation could be involved in the levels of blood cholesterol, but there is no evidence for the utility of APOE methylation as a biomarker for predicting AD or CVD.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease 95%
- DNA methylation age acceleration is associated with incident cognitive impairment in the Health and Retirement Study 95%
- An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease 94%
Similar papers in this journal
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 96%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 95%
- Inflammation in Alzheimer's disease: do sex and APOE matter? 95%
Similar papers in this journal
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 95%
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 94%
- Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer’s disease 93%